心血管病探索(英文)(Cardiology Discovery) 知网目次万方目次维普目次
- 科核
- 主管单位:
中国科学技术协会
- 主办单位:
中华医学会
- 国际刊号:
2096-952X;EISSN2693-8499
- 国内刊号:
10-1724/R
- 学科分类:
- 字数:
8000-48000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-季刊
- 特殊属性:
外文期刊
- 电话:
010-51322215,51322216,010-51322217
- 邮箱:
cdcardioldiscov@126.com;CD@cmaph.org(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次,万方目次,维普目次
- 级别:
科核
期刊简介
《心血管病探索》期刊已被查看: 次
更新频次
高频栏目:
Original Articles-100%-期平均发文量2篇
Case Report-100%-期平均发文量1篇
中频栏目:
Consensus and Guideline-50.0%-期平均发文量1篇
Meta Analysis-50.0%-期平均发文量1篇
Hot Topic-50.0%-期平均发文量2篇
Special Article-50.0%-期平均发文量1篇
State of the Art-50.0%-期平均发文量5篇
单位占比
其他-100.0%一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、官网网址:http://www.cardio-discovery.org
自动跳转:
https://journals.lww.com/cd/pages/default.aspx
3、投稿网址:
https://www.editorialmanager.com/Cardiodiscovery
4、中华医学期刊全文数据库:
https://www.yiigle.com/Journal/Detail/197
5、出刊日期:季刊,逢季末月出版。
2024年2月23日星期五
《心血管病探索(英文)》投稿须知
【官网信息】
Cardiology Discovery
Instructions for Authors
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.
Email: cdcardioldiscov@126.com
AIMS AND SCOPE
Cardiology Discovery (CD) is the official journal of the Chinese Society of Cardiology (CSC) of Chinese Medical Association (CMA). It is an English language, peer-reviewed journal aims to publish high-quality materials on all aspects of cardiovascular medicine and surgery, including original clinical, epidemiological, basic and translational research, health services and outcomes studies, state-of-the-art reviews, technical evaluations, case reports, editorial, perspective, consensus and guideline papers. CD has an international outlook, that is to create a platform of international collaboration and exchange of cutting-edge information on cardiovascular research and education.
Articles are published quarterly. The journal is available both in print and online.
ONLINE SUBMISSION
All manuscripts must be submitted online at: https://www.editorialmanager.com/Cardiodiscovery. Once the manuscript has been created, visit the submission site to upload the manuscript. Once the manuscript has been vetted for compliance to the Journal’s requirements, a manuscript number will be assigned to the submission. Failure to adhere to these guidelines will result in your manuscript being returned to you for correction. Faxed, scanned or emailed copies of manuscripts will not be accepted.
First-time users
Please click the Register button at https://www.editorialmanager.com/Cardiodiscovery. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.
Authors
Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.
JOURNAL POLICIES
Duplicate Publication
Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Cardiology Discovery and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in Cardiology Discovery to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example: “Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared.”
Authorship
Cardiology Discovery expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author’s specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:
Participated in research design
Participated in the writing of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.
English Language Assistance
Appropriate use of the English language is a requirement for publication in Journal name. Authors who have difficulty in writing in English who submit manuscripts to international journals often receive negative comments from referees or editors about the English-language usage in their manuscripts, and these challenges can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors consider using Wolters Kluwer Author Services**.
……
更多详情请查看期刊官网信息:
https://edmgr.ovid.com/cardiologydiscovery/accounts/ifauth.htm
上一篇:实证社会科学(集刊)下一篇:跨文化管理(集刊)
《心血管病探索》同类内科学期刊
-
中华胃肠外科杂志(原:中国胃肠外科杂志)
北核,CSCD,科核,武A,高T2
CN中文-月刊影响因子1.903
-
肠外与肠内营养
北核,CSCD,科核,武A+,高T3
CN中文-双月刊影响因子1.694
-
中华心血管病杂志
北核,CSCD,科核,武A+,高T1
CN中文-月刊影响因子2.576
-
中国糖尿病杂志
北核,CSCD,科核,武A
CN中文-月刊影响因子1.554
-
中国老年学杂志
北核,武A+
CN中文-半月刊影响因子1.791
-
中国实用内科杂志
北核,CSCD,科核,武A
CN中文-月刊影响因子1.51
-
中国呼吸与危重监护杂志
CSCD,科核,武A-,高T3
CN中文-月刊影响因子1.753
-
中华风湿病学杂志
科核,CSCD扩,武B+
CN中文-月刊影响因子0.744
常见问题
-
心血管病探索杂志社官网、联系方式是什么?
心血管病探索杂志社官网:https://journals.lww.com/cd/pages/default.aspx
投稿网址:https://www.editorialmanager.com/Cardiodiscovery联系电话:010-51322215,51322216,010-51322217
投稿邮箱:cdcardioldiscov@126.com;CD@cmaph.org(官网邮箱) -
心血管病探索杂志是核心期刊么?
心血管病探索是核心期刊,级别是:科核, 是:内科学分类下的知网目次,万方目次,维普目次收录的期刊。
-
请问你们是心血管病探索杂志社吗?
我们不是《心血管病探索》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
-
你们指导服务后可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
晋级论文能否在报纸上发表?
在学术界,论文的发表往往被视为研究者职业发展的重要一环。晋级论文,即为了获得更高职称或学术地位而撰写的学术论文,通常需在专业期刊上发表。然而,许多人可能会问